Home Michal Marszal, CFA
Michal Marszal

Michal Marszal, CFA

Michal Marszal is a Senior Analyst with Equities – Healthcare at CIBC.

He is responsible for research coverage and stock selection within the global healthcare sector.

Prior to joining CIBC AM in 2017, Mr. Marszal was a senior healthcare analyst for the Global Quality Equity Portfolio at Caisse de dépôt et placement du Québec. Previously, he was a senior healthcare analyst, principally focusing on global therapeutics, for the 1798 Fundamental Strategies Fund at Lombard Odier Investment Managers. Mr. Marszal began his investment career as an analyst covering global medical technology, and subsequently global biotechnology companies at Sectoral Asset Management.

Mr. Marszal holds a Doctor of Medicine and Master of Surgery degree from McGill University. Upon graduating from medical school, he joined the Neurological Surgery Residency training program at Stanford University Medical Center as a resident physician. Mr. Marszal also holds an MBA degree in Finance from McGill University and a Bachelor of Arts degree in Molecular Biology from Bard College. He is a CFA charterholder.

Pfizer and Moderna continue to come out on top.

  • January 12, 2022 January 12, 2022
  • 17:30

Understanding innovation in the sector helps reveal top stocks.

  • May 31, 2021 June 3, 2021
  • 17:30

The lockdown is creating winners and losers.

  • May 25, 2020 May 28, 2020
  • 16:00

Companies working on virus treatments are being closely watched.

  • April 29, 2020 May 5, 2020
  • 16:00